Medtronic’s CoreValve Evolut R “Recapturable” TAVR Earns CE Mark

The next-generation version of the CoreValve transcatheter aortic valve can be repositioned during the implant procedure.

Medtronic PLC has entered the European market with its first recapturable, repositionable transcatheter aortic valve with the Sept. 3 CE mark of its 23 mm CoreValve Evolut R device.

The valve will compete directly in Europe with other second-generation, repositionable valves, including Boston Scientific Corp.Lotus, valves from

More from Archive

More from Medtech Insight